Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STXB
2101
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $2.38M | ﹤0.01% |
192,900
+27,600
| +17% | +$312K |
|
2102
Educational Development Corp
EDUC
$11.8M
| $2.36M | ﹤0.01% |
244,138
+15,400
| +7% | +$96.8K |
|
2103
ADT
ADT
$5.47B
| $2.36M | ﹤0.01% |
295,700
-344,800
| -54% | -$2.23M |
|
|
CSLT
2104
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.36M | ﹤0.01% |
2,843,700
+549,500
| +24% | +$408K |
|
2105
ICU Medical
ICUI
$4.58B
| $2.36M | ﹤0.01% |
12,800
+10,400
| +433% | +$2.07M |
|
2106
Gentherm
THRM
$1.35B
| $2.35M | ﹤0.01% |
60,464
-5,100
| -8% | -$193K |
|
|
LSXMA
2107
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.34M | ﹤0.01% |
92,412
-330,303
| -78% | -$8.08M |
|
|
ALO
2108
DELISTED
Alio Gold Inc
ALO
| $2.34M | ﹤0.01% |
1,856,445
+58,500
| +3% | +$47.7K |
|
|
ACH
2109
DELISTED
Alum Corp of China Ltd
ACH
| $2.32M | ﹤0.01% |
493,829
+12,229
| +3% | +$61K |
|
2110
Air T
AIRT
$79.2M
| $2.32M | ﹤0.01% |
197,411
-6,300
| -3% | -$76.8K |
|
|
PRCP
2111
DELISTED
Perceptron Inc
PRCP
| $2.32M | ﹤0.01% |
699,683
+56,569
| +9% | +$166K |
|
2112
Greif Class B
GEF.B
$4.2B
| $2.31M | ﹤0.01% |
55,310
-8,100
| -13% | -$317K |
|
|
CLPR
2113
Clipper Realty
CLPR
$54M
| $2.31M | ﹤0.01% |
284,757
+34,970
| +14% | +$219K |
|
|
FRBK
2114
DELISTED
Republic First Bancorp Inc
FRBK
| $2.29M | ﹤0.01% |
939,646
+17,100
| +2% | +$39.4K |
|
|
DSKE
2115
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.29M | ﹤0.01% |
581,610
+245,113
| +73% | +$540K |
|
2116
Espey Mfg & Electronics Corp
ESP
$192M
| $2.28M | ﹤0.01% |
131,464
-4,200
| -3% | -$78.3K |
|
|
HPR
2117
DELISTED
HighPoint Resources Corporation
HPR
| $2.28M | ﹤0.01% |
154,369
-29,209
| -16% | -$424K |
|
2118
Community Bank
CBU
$3.46B
| $2.27M | ﹤0.01% |
39,808
+23,108
| +138% | +$1.36M |
|
|
WHWK
2119
Whitehawk Therapeutics
WHWK
$254M
| $2.27M | ﹤0.01% |
121,058
+90,949
| +302% | +$1.19M |
|
|
EXTN
2120
DELISTED
Exterran Corporation
EXTN
| $2.27M | ﹤0.01% |
420,600
-275,700
| -40% | -$1.56M |
|
|
ONDK
2121
DELISTED
On Deck Capital, Inc.
ONDK
| $2.27M | ﹤0.01% |
3,152,233
-1,145,683
| -27% | -$1.13M |
|
|
KZR
2122
DELISTED
Kezar Life Sciences
KZR
| $2.26M | ﹤0.01% |
43,662
+36,520
| +511% | +$1.84M |
|
|
AGS
2123
DELISTED
PlayAGS
AGS
| $2.26M | ﹤0.01% |
668,660
+419,800
| +169% | +$1.61M |
|
2124
Core Molding Technologies
CMT
$224M
| $2.26M | ﹤0.01% |
547,864
+19,401
| +4% | +$62.4K |
|
|
GWB
2125
DELISTED
Great Western Bancorp, Inc.
GWB
| $2.24M | ﹤0.01% |
162,944
+135,333
| +490% | +$2.15M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.